AI-generated summary
The authors randomized patients undergoing coronary angioplasty to intracoronary 808 nm low-level laser therapy or a control group and measured serum growth factors over time. They report lower FGF-2 levels in the irradiated patients, no significant IGF-1 or VEGF differences, and a restenosis rate of 15.0% versus 32.4%. The authors suggest this may explain smaller neointima formation.
- Who or what was studied
- Patients undergoing percutaneous coronary intervention (52 irradiated, 49 control)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract does not describe blinding or long-term follow-up beyond the 6-month angiography, and it reports a mechanistic link to neointima formation that is suggested rather than demonstrated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 9 J/cm2
- Power density (irradiance)
- 100 mW/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.